Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
0.79Price to Book
VS
Market
Sector
Industry
History
$ 10.05Close
$ 4.84 - $ 18.61 52-Week Range
Ticker Information
Ticker
NEOCompany Name
NEOGENOMICS INCSector
HealthcareIndustry
Diagnostics & ResearchExchange
NASDAQNEOGENOMICS INC - Price to Book Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
NEO - P/B Historical data
| Date | Shareholders Equity | Market Capitalization | Price to Book |
|---|---|---|---|
| 6/30/2025 | $ 854.04M | $ 678.19M | 0.79 |
| 3/31/2025 | $ 888.27M | $ 846.81M | 0.95 |
| 12/31/2024 | $ 902.34M | $ 1.59B | 1.77 |
| 9/30/2024 | $ 908.21M | $ 1.92B | 2.11 |
| 6/30/2024 | $ 915.88M | $ 2.21B | 2.42 |
| 3/31/2024 | $ 923.41M | $ 1.78B | 1.93 |
| 12/31/2023 | $ 941.54M | $ 1.88B | 1.99 |
| 9/30/2023 | $ 947.43M | $ 1.87B | 1.97 |
| 6/30/2023 | $ 956.19M | $ 1.95B | 2.04 |
| 3/31/2023 | $ 974.46M | $ 2.33B | 2.39 |
Key Performance Insights, Last 5 Years
- NEOGENOMICS INC's latest trailing twelve months (TTM) P/B stands at 6.89.
- Over the past 5 years, NEOGENOMICS INC's average P/B has been 2.83.
- The median P/B for NEOGENOMICS INC during this period was 2.03
- NEOGENOMICS INC reached its highest P/B over the past 5 years at 8.57.
- The lowest P/B recorded by NEOGENOMICS INC in the same timeframe 0.79
NEOGENOMICS INC's P/B vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
P/B Benchmarks
Similar metrics to P/B:
- Price to Sales - [Calculation] Measures a company’s [MarketCap] in relation to its [Revenue].
- Free Cash Flow Yield - [Calculation] The Free Cash Flow Yield, also known as the inverse of the Price to Free Cash Flow ratio [PFCF], expresses a company’s Free Cash Flow [FCF] as a percentage of [MarketCap.
- Price to Free Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Free Cash Flow [FCF].
- Price to Operating Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Operating Cash Flow [NCFO].
- Shareholders Equity - [Balance Sheet] A principal component of the balance sheet; in addition to [Liabilities] and [Assets]; that represents the total of all stockholders' equity (deficit) after all liabilities have been deducted.
Definition of Price to Book
[Calculation] Measures a company’s [MarketCap] in relation to its [Equity] which is the value of [Assets] minus [Liabilities].Market Cap / Equity
(=) P/B P/B for NEOGENOMICS INC is calculated as follows: Market Cap [ $ 4.59B ] / Equity [ $ 666.36M ]
(=) P/B [ 6.89 ] NEO - Price to Book, Last 5 years
0.79
Minimum
Jun 30, 2025
8.57
Maximum
Dec 31, 2020
2.83
Average
2.03
Median
P/B Benchmark AnalysisMarket
The chart above depicts the distribution of P/B for companies in the Total Stock Market. The average P/B of the companies is 2.29 with a standard deviation of 1.81.
The following table provides additional summary stats:
P/B in the Market:
| filtered constituents | 3.36K |
|---|---|
| min | 0 |
| max | 8.04 |
| average | 2.29 |
| median | 1.63 |
| std | 1.81 |